SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS IN BIOLOGICAL TREATMENT OVER 65 YEARS OF AGE

被引：0
作者：
Crespo Golmar, A.
Moriano, C.
Gonzalez Fernandez, I.
Larco Rojas, X. E.
Lopez Robles, A.
Perez Sandoval, T.
机构：
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2020年 / 79卷
关键词：
D O I：
10.1136/annrheumdis-2020-eular.5260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
SAT0622-HP
引用
收藏
页码：1267 / 1267
页数：1
相关论文
共 3 条
[1]   Drug tolerability and reasons for discontinuation of seven biologics in elderly patients with rheumatoid arthritis-The ANSWER cohort study- [J].
Ebina, Kosuke ;
Hashimoto, Motomu ;
Yamamoto, Wataru ;
Hirano, Toru ;
Hara, Ryota ;
Katayama, Masaki ;
Onishi, Akira ;
Nagai, Koji ;
Son, Yonsu ;
Amuro, Hideki ;
Yamamoto, Keiichi ;
Maeda, Yuichi ;
Murata, Koichi ;
Jinno, Sadao ;
Takeuchi, Tohru ;
Hirao, Makoto ;
Kumanogoh, Atsushi ;
Yoshikawa, Hideki .
PLOS ONE, 2019, 14 (05)
[2]   Safety and Efficacy of Biological Disease-Modifying Antirheumatic Drugs in Older Rheumatoid Arthritis Patients: Staying the Distance [J].
Ishchenko, Alla ;
Lories, Rik J. .
DRUGS & AGING, 2016, 33 (06) :387-398
[3]   Safety of Biologic Agents in Elderly Patients with Rheumatoid Arthritis [J].
Murota, Atsuko ;
Kaneko, Yuko ;
Yamaoka, Kunihiro ;
Takeuchi, Tsutomu .
JOURNAL OF RHEUMATOLOGY, 2016, 43 (11) :1984-1988
1